Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TWILIGHT
2014-005498-35Phase 4Completed
- Sponsor
- Icagen
- Start
- Dec 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in coronary arteriosclerosis comparing Ticagrelor monotherapy with Ticagrelor plus aspirin (2 arms). Primary endpoint: Clinically relevant bleeding. Started Dec 2015; status: completed.
02
Drugs
ticagreloraspirin
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on 2014-005498-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005498-35.